Evaxion - Operating Margin 2020-2025 | EVAX
Current and historical operating margin for Evaxion - (EVAX) over the last 10 years. The current operating profit margin for Evaxion - as of March 31, 2025 is -316.03%.
| Evaxion - Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.003B | $0.003B |
| Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.229B | 58.81 |
| Doximity (DOCS) | United States | $10.965B | 50.76 |
| Hims & Hers Health (HIMS) | United States | $10.735B | 111.54 |
| Tempus AI (TEM) | United States | $10.291B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.659B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.858B | 60.28 |
| Hinge Health (HNGE) | United States | $3.535B | 0.00 |
| Privia Health (PRVA) | United States | $2.748B | 187.83 |
| Enovis (ENOV) | United States | $1.886B | 10.52 |
| Phreesia (PHR) | United States | $1.695B | 0.00 |
| Schrodinger (SDGR) | United States | $1.512B | 0.00 |
| 10x Genomics (TXG) | United States | $1.485B | 0.00 |
| Azenta (AZTA) | United States | $1.454B | 67.57 |
| Omnicell (OMCL) | United States | $1.402B | 24.74 |
| Clover Health Investments (CLOV) | United States | $1.400B | 0.00 |
| Evolent Health (EVH) | United States | $1.365B | 116.30 |
| Claritev (CTEV) | United States | $0.717B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.606B | 0.00 |
| Veradigm (MDRX) | United States | $0.509B | 0.00 |
| Standard BioTools (LAB) | United States | $0.490B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.480B | 0.00 |
| Talkspace (TALK) | United States | $0.452B | 135.00 |
| Outset Medical (OM) | United States | $0.367B | 0.00 |
| TruBridge (TBRG) | United States | $0.353B | 782.67 |
| Health Catalyst (HCAT) | United States | $0.282B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.219B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.170B | 0.00 |
| American Well (AMWL) | United States | $0.131B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| Pulmonx (LUNG) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.096B | 3.66 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.050B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.041B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |